Table 6.
Percentage reduction in projected cumulative COVID-19 mortality on April 10, 2021, in relation to the cumulative mortality in the absence of vaccination (511, 100 COVID-19 deaths on April 10, 2021), for the three vaccines considered in this study: AstraZeneca vaccine (efficacy εv = 0.7); Pfizer and/or Moderna vaccine (efficacy εv = 0.95), and various levels of increases in baseline social-distancing compliance attained on October 12, 2020 (cs) and vaccination rate (ξv). SD, social-distancing compliance.
| Reduction with | Reduction with | Reduction with | ||||
|---|---|---|---|---|---|---|
| Number of people | Baseline SD (cs = 0) | cs = 0.05 | cs = 0.10 | |||
| vaccinated per day | εv = 70% | εv = 95% | εv = 70% | εv = 95% | εv = 70% | εv = 95% |
| 250,000 | 9% | 12% | 25% | 27% | 35% | 36% |
| 500,000 | 16% | 20% | 29% | 32% | 38% | 39% |
| 1,000,000 | 26% | 31% | 35% | 38% | 41% | 43% |